Skip to main content
Top
Published in: Urolithiasis 6/2018

01-11-2018 | Original Paper

Uric acid stones increase the risk of chronic kidney disease

Authors: Ching-Chia Li, Tsu-Ming Chien, Wen-Jeng Wu, Chun-Nung Huang, Yii-Her Chou

Published in: Urolithiasis | Issue 6/2018

Login to get access

Abstract

The aim of this study was to compare the clinical characteristics of uric acid stones and their potential risk for chronic kidney disease (CKD). A total of 401 patients (196 with uric acid stone and 205 without) were enrolled from our database of patients with urolithiasis. We analyzed the clinical demographic features, stone location, urine chemistries, and renal function. There was a significant difference (p < 0.001) between the two groups in terms of age, with the higher mean age in the uric acid group. Patients with uric acid stones had much lower pH of urine (p < 0.001) and higher serum uric acid level (p = 0.002). Notably, those with uric acid stones had worse eGFR than those with non-uric acid stones. Multivariate analysis confirmed that age over 60 years (ORs = 9.19; 95% CI 3.5–24.3), female sex (ORs = 4.01; 95% CI 1.8-9.0), hyperuricemia (ORs = 8.47; 95% CI 1.6–43.5), and uric acid stone (OR = 2.86; 95% CI 1.2–6.7) were the independent predictors of poor prognoses in CKD. Therefore, an association exists between uric acid stones and higher prevalence of CKD. Patients with uric acid stones may need close monitoring of renal function during follow-up.
Appendix
Available only for authorised users
Literature
1.
2.
3.
go back to reference Sakhaee K (2014) Epidemiology and clinical pathophysiology of uric acid kidney stones. J Nephrol 27:241–245CrossRefPubMed Sakhaee K (2014) Epidemiology and clinical pathophysiology of uric acid kidney stones. J Nephrol 27:241–245CrossRefPubMed
5.
go back to reference Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033CrossRefPubMed Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033CrossRefPubMed
6.
go back to reference Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2:883–888CrossRefPubMed Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2:883–888CrossRefPubMed
7.
go back to reference Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, Mazzaferro S, D’Addessi A, Ferraro PM (2017) The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J Urol 198:268–273CrossRefPubMed Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, Mazzaferro S, D’Addessi A, Ferraro PM (2017) The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J Urol 198:268–273CrossRefPubMed
8.
go back to reference Haley WE, Enders FT, Vaughan LE, Mehta RA, Thoman ME, Vrtiska TJ, Krambeck AE, Lieske JC, Rule AD (2016) Kidney function after the first kidney stone event. Mayo Clin Proc 91:1744–1752CrossRefPubMed Haley WE, Enders FT, Vaughan LE, Mehta RA, Thoman ME, Vrtiska TJ, Krambeck AE, Lieske JC, Rule AD (2016) Kidney function after the first kidney stone event. Mayo Clin Proc 91:1744–1752CrossRefPubMed
9.
go back to reference Rule AD, Krambeck AE, Lieske JC (2011) Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 6:2069–2075CrossRefPubMed Rule AD, Krambeck AE, Lieske JC (2011) Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 6:2069–2075CrossRefPubMed
10.
go back to reference Chou YH, Li CC, Hsu H, Chang WC, Liu CC, Li WM, Ke HL, Lee MH, Liu ME, Pan SC, Wang HS (2011) Renal function in patients with urinary stones of varying compositions. Kaohsiung J Med Sci 27:264–267CrossRefPubMed Chou YH, Li CC, Hsu H, Chang WC, Liu CC, Li WM, Ke HL, Lee MH, Liu ME, Pan SC, Wang HS (2011) Renal function in patients with urinary stones of varying compositions. Kaohsiung J Med Sci 27:264–267CrossRefPubMed
11.
go back to reference Worcester EM1, Parks JH, Evan AP (2006) Renal function in patients with nephrolithiasis. J Urol 176:600–603CrossRefPubMed Worcester EM1, Parks JH, Evan AP (2006) Renal function in patients with nephrolithiasis. J Urol 176:600–603CrossRefPubMed
12.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMed Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMed
13.
go back to reference Denburg MR, Jemielita TO, Tasian GE, Haynes K, Mucksavage P, Shults J, Copelovitch L (2015) Assessing the risk of incident hypertension and chronic kidney disease after exposure to shockwave lithotripsy and ureteroscopy. Kidney Int 89:185–192CrossRef Denburg MR, Jemielita TO, Tasian GE, Haynes K, Mucksavage P, Shults J, Copelovitch L (2015) Assessing the risk of incident hypertension and chronic kidney disease after exposure to shockwave lithotripsy and ureteroscopy. Kidney Int 89:185–192CrossRef
14.
go back to reference Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38:147–160CrossRefPubMed Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38:147–160CrossRefPubMed
15.
go back to reference Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL (2003) Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 64:2204–2213CrossRefPubMed Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL (2003) Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 64:2204–2213CrossRefPubMed
16.
go back to reference Gaudio KM, Siegel NJ, Hayslett JP, Kashgarian M (1980) Renal perfusion and intratubular pressure during ureteral occlusion in the rat. Am J Physiol 238:F205–F209PubMed Gaudio KM, Siegel NJ, Hayslett JP, Kashgarian M (1980) Renal perfusion and intratubular pressure during ureteral occlusion in the rat. Am J Physiol 238:F205–F209PubMed
18.
go back to reference Klahr S, Morrissey J (2003) Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl 87:105–112CrossRef Klahr S, Morrissey J (2003) Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl 87:105–112CrossRef
19.
go back to reference Kadlec AO, Greco KA, Fridirici ZC, Gerber D, Turk TM (2011) Effect of renal function on urinary mineral excretion and stone composition. Urology 78:744–747CrossRefPubMed Kadlec AO, Greco KA, Fridirici ZC, Gerber D, Turk TM (2011) Effect of renal function on urinary mineral excretion and stone composition. Urology 78:744–747CrossRefPubMed
20.
go back to reference Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD (2011) Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6:2364–2373CrossRefPubMed Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD (2011) Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6:2364–2373CrossRefPubMed
21.
go back to reference Viazzi F, Garneri D, Leoncini G, Gonnella A, Muiesan ML, Ambrosioni E et al (2014) Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study. Nutr Metab Cardiovasc Dis 24:921–927CrossRefPubMed Viazzi F, Garneri D, Leoncini G, Gonnella A, Muiesan ML, Ambrosioni E et al (2014) Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study. Nutr Metab Cardiovasc Dis 24:921–927CrossRefPubMed
22.
go back to reference Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE (2003) A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41:733–741CrossRef Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE (2003) A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41:733–741CrossRef
23.
go back to reference Bagby SP (2004) Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? J Am Soc Nephrol 15:2775–2791CrossRefPubMed Bagby SP (2004) Obesity-initiated metabolic syndrome and the kidney: A recipe for chronic kidney disease? J Am Soc Nephrol 15:2775–2791CrossRefPubMed
24.
go back to reference Schelling JR, Sedor JR (2004) The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? J Am Soc Nephrol 15:2773–2774CrossRefPubMed Schelling JR, Sedor JR (2004) The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance? J Am Soc Nephrol 15:2773–2774CrossRefPubMed
25.
go back to reference Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Fioretto P, De Cosmo S, Pontremoli R, AMD-Annals Study Group (2017) Metabolic syndrome, serum uric acid and renal risk in patients with T2D. PLoS One 12:e0176058CrossRefPubMed Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo G, Guida P, Fioretto P, De Cosmo S, Pontremoli R, AMD-Annals Study Group (2017) Metabolic syndrome, serum uric acid and renal risk in patients with T2D. PLoS One 12:e0176058CrossRefPubMed
26.
go back to reference Chou YC, Kuan JC, Yang T, Chou WY, Hsieh PC, Bai CH, You SL, Chen CH, Wei CY, Sun CA (2015) Elevated uric acid level as a significant predictor of chronic kidney disease: a cohort study with repeated measurements. J Nephrol 28:457–462CrossRefPubMed Chou YC, Kuan JC, Yang T, Chou WY, Hsieh PC, Bai CH, You SL, Chen CH, Wei CY, Sun CA (2015) Elevated uric acid level as a significant predictor of chronic kidney disease: a cohort study with repeated measurements. J Nephrol 28:457–462CrossRefPubMed
27.
go back to reference Sairam K, Scoffone CM, Alken P, Turna B, Sodha HS, Rioja J, Wolf JS Jr, de la Rosette JJ, CROES PCNL Study Group (2012) Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL Global Study. J Urol 188:1195–1200CrossRefPubMed Sairam K, Scoffone CM, Alken P, Turna B, Sodha HS, Rioja J, Wolf JS Jr, de la Rosette JJ, CROES PCNL Study Group (2012) Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL Global Study. J Urol 188:1195–1200CrossRefPubMed
28.
go back to reference Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29: 715–734CrossRefPubMed Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29: 715–734CrossRefPubMed
Metadata
Title
Uric acid stones increase the risk of chronic kidney disease
Authors
Ching-Chia Li
Tsu-Ming Chien
Wen-Jeng Wu
Chun-Nung Huang
Yii-Her Chou
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
Urolithiasis / Issue 6/2018
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-018-1050-1

Other articles of this Issue 6/2018

Urolithiasis 6/2018 Go to the issue